scispace - formally typeset
A

Aurélien Guffroy

Researcher at University of Strasbourg

Publications -  50
Citations -  766

Aurélien Guffroy is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Medicine & Immunodeficiency. The author has an hindex of 8, co-authored 44 publications receiving 346 citations. Previous affiliations of Aurélien Guffroy include Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre-Louis Tharaux, +600 more
TL;DR: Anakinra did not improve outcomes in patients with mild-to-moderate COVID-19 pneumonia, and further studies are needed to assess the efficacy of anakinra in other selected groups of patients with more severe CO VID-19.
Journal ArticleDOI

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.

TL;DR: Although these treatments could be an interesting potential strategy to limit progression toward uncontrolled inflammation, they do not appear per se sufficiently potent to control the whole inflammatory process in COVID-19, and more targeted and/or potent therapies should be required at least in add-on.
Journal ArticleDOI

10 most important contemporary challenges in the management of SLE.

TL;DR: These 10 contemporary challenges in SLE may be considered as a roadmap for those involved in the daily care of patients with SLE, as well as for researchers who may wish to contribute to an improved management of this rare and complex disease.
Journal ArticleDOI

Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes

TL;DR: “Anti-Ku with elevated CK” syndrome and “anti- Ku with anti-dsDNA’ syndrome represent two distinct entities that are important to recognise in order to best tailor patient care.